Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

BioNexus Gene Lab (BGLC) Receivables - Other (2018 - 2025)

BioNexus Gene Lab's Receivables - Other history spans 8 years, with the latest figure at $81728.0 for Q4 2025.

  • Quarterly results put Receivables - Other at $81728.0 for Q4 2025, down 59.87% from a year ago — trailing twelve months through Dec 2025 was $81728.0 (down 59.87% YoY), and the annual figure for FY2025 was $81728.0, down 59.87%.
  • Receivables - Other for Q4 2025 was $81728.0 at BioNexus Gene Lab, down from $98903.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $400830.0 in Q2 2024 to a low of $22933.0 in Q1 2021.
  • The 5-year median for Receivables - Other is $80552.0 (2021), against an average of $103017.0.
  • The sharpest move saw Receivables - Other tumbled 68.26% in 2022, then skyrocketed 744.19% in 2024.
  • Year by year, Receivables - Other stood at $79517.0 in 2021, then tumbled by 68.26% to $25240.0 in 2022, then soared by 385.07% to $122432.0 in 2023, then skyrocketed by 66.35% to $203660.0 in 2024, then plummeted by 59.87% to $81728.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $81728.0, $98903.0, and $151269.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.